miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1

Published:2016-07-26 Issue:37 Volume:7 Page:59714-59726
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Gao Man¹,Miao Lingling¹,Liu Mingxia¹,Li Chenggang¹,Yu Cunzhi¹,Yan Hong¹,Yin Yongxiang²,Wang Yizheng³,Qi Xinming¹,Ren Jin¹

Affiliation:

1. Center for Drug Safety Evaluation and Research, Shanghai Institute of Materia Medica, CAS., Shanghai, P.R. China

2. Department of Pathology, Wuxi Maternity and Children Health Hospital Affiliated Nanjing Medical University, Wuxi, China

3. The Brain Science Center, Beijing Institute of Basic Medical Sciences, Beijing, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision-engineered PEGylated liposome for dual payload delivery: enhancing efficacy of Doxorubicin hydrochloride and miR-145 mimics in breast cancer cells;Journal of Liposome Research;2024-08-05

2. Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs;Frontiers in Pharmacology;2024-07-24

3. Interplay between Wnt signaling molecules and exosomal miRNAs in breast cancer (Review);Oncology Reports;2024-06-28

4. Resistance to gemcitabine is mediated by the circ_0036627/miR‐145/S100A16 axis in pancreatic cancer;Journal of Cellular and Molecular Medicine;2024-06

5. Exosomal miR-122-3p represses the growth and metastasis of MCF-7/ADR cells by targeting GRK4-mediated activation of the Wnt/β-catenin pathway;Cellular Signalling;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3